TrialAnnals of oncology : official journal of the European Society for Medical Oncology2012

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.

P Vici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.